Key Points
- Biosig chairman Morgan Lee Lekstrom purchased 20,000 shares on February 18 at an average price of $2.50, increasing his holdings to 122,500 shares (a 19.51% boost).
- He has been buying heavily in January–February, acquiring a total of 115,500 shares across six trades for roughly $352,550, indicating significant insider accumulation.
- The stock opened at $2.38 and was trading down 6.3%, while analyst sentiment is negative—Weiss Ratings initiated coverage with a "sell (d-)" and MarketBeat shows an average rating of "Sell."
Biosig Technologies, Inc. (NASDAQ:STEX - Get Free Report) Chairman Morgan Lee Lekstrom purchased 20,000 shares of the company's stock in a transaction on Wednesday, February 18th. The stock was purchased at an average price of $2.50 per share, with a total value of $50,000.00. Following the completion of the transaction, the chairman owned 122,500 shares of the company's stock, valued at approximately $306,250. This trade represents a 19.51% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Morgan Lee Lekstrom also recently made the following trade(s):
- On Tuesday, February 3rd, Morgan Lee Lekstrom acquired 23,500 shares of Biosig Technologies stock. The shares were purchased at an average price of $3.06 per share, for a total transaction of $71,910.00.
- On Thursday, January 29th, Morgan Lee Lekstrom acquired 2,500 shares of Biosig Technologies stock. The shares were purchased at an average price of $3.70 per share, for a total transaction of $9,250.00.
- On Monday, January 26th, Morgan Lee Lekstrom bought 23,000 shares of Biosig Technologies stock. The shares were purchased at an average price of $3.30 per share, for a total transaction of $75,900.00.
- On Tuesday, January 27th, Morgan Lee Lekstrom bought 5,500 shares of Biosig Technologies stock. The stock was purchased at an average cost of $3.12 per share, with a total value of $17,160.00.
- On Friday, January 23rd, Morgan Lee Lekstrom purchased 41,000 shares of Biosig Technologies stock. The stock was acquired at an average price of $3.13 per share, with a total value of $128,330.00.
Biosig Technologies Trading Down 6.3%
NASDAQ:STEX opened at $2.38 on Thursday. Biosig Technologies, Inc. has a 52 week low of $0.40 and a 52 week high of $14.11. The stock has a market cap of $379.85 million, a price-to-earnings ratio of -1.76 and a beta of 1.50.
Wall Street Analyst Weigh In
Separately, Weiss Ratings started coverage on Biosig Technologies in a report on Friday, January 23rd. They issued a "sell (d-)" rating on the stock. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has an average rating of "Sell".
Get Our Latest Research Report on STEX
About Biosig Technologies
(
Get Free Report)
Biosig Technologies (NASDAQ:STEX) is a medical technology company focused on developing advanced signal acquisition and processing solutions for cardiac electrophysiology. The company’s work centers on improving the clarity and interpretability of intracardiac signals captured during electrophysiology procedures, with the goal of helping clinicians identify arrhythmogenic substrates and make more informed procedural decisions.
Its primary offering is a signal-processing platform that combines proprietary hardware and software to amplify, filter and display intracardiac electrical activity with reduced noise and distortion.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
